Phase 2 Multicentre Trial Investigating Intermittent and Continuous Dosing Schedules of the Poly(ADP-Ribose) Polymerase Inhibitor Rucaparib in Germline BRCA Mutation Carriers With Advanced Ovarian and Breast Cancer
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.41
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Springer Science and Business Media LLC